{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:08:12Z","timestamp":1788836892637,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cjca.2026.03.051","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:36:49Z","timestamp":1775633809000},"page":"2211-2219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three-Point Correction Factor Improves Accuracy of Framingham Risk Score in Breast Cancer Survivors"],"prefix":"10.1016","volume":"42","author":[{"given":"Julia N.","family":"Rickard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.G.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Abdel-Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Santa Mina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3847-1225","authenticated-orcid":false,"given":"Amy A.","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2026.03.051_bib2","series-title":"Breast Cancer: Diagnosis and Treatment: An Assessment of Need. Cardiff (UK)","author":"Dewis","year":"2009"},{"key":"10.1016\/j.cjca.2026.03.051_bib5","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr2901","article-title":"Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study","volume":"13","author":"Patnaik","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.cjca.2026.03.051_bib6","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.03.051_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.med.57.121304.131240","article-title":"Cardiotoxicity induced by chemotherapy and antibody therapy","volume":"57","author":"Yeh","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cjca.2026.03.051_bib8","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2026.03.051_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pcad.2019.02.002","article-title":"Curing breast cancer and killing the heart: a novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer","volume":"62","author":"Kirkham","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2026.03.051_bib10","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.3747\/co.27.6117","article-title":"Age-dependent increased odds of cardiovascular risk factors in cancer survivors: Canadian Longitudinal Study on Aging cohort","volume":"27","author":"Kirkham","year":"2020","journal-title":"Curr Oncol"},{"key":"10.1016\/j.cjca.2026.03.051_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gheart.2013.01.001","article-title":"Cardiovascular disease risk assessment: insights from Framingham","volume":"8","author":"D\u2019Agostino","year":"2013","journal-title":"Glob Heart"},{"key":"10.1016\/j.cjca.2026.03.051_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.03.051_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015634","article-title":"State of the science in women\u2019s cardiovascular disease: a Canadian perspective on the influence of sex and gender","volume":"9","author":"Norris","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2026.03.051_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-018-4723-0","article-title":"The risk of cardiovascular disease following breast cancer by Framingham Risk Score","volume":"170","author":"Gernaat","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cjca.2026.03.051_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ije\/dym276","article-title":"The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine","volume":"37","author":"Elliott","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cjca.2026.03.051_bib21","author":"Fry"},{"key":"10.1016\/j.cjca.2026.03.051_bib22","first-page":"417","article-title":"Practical use of the Framingham Risk Score in primary prevention Canadian perspective","volume":"57","author":"Bosomworth","year":"2011","journal-title":"Can Fam Phys"},{"key":"10.1016\/j.cjca.2026.03.051_bib23","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.03.051_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjca.2026.03.051_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-017-4282-9","article-title":"Risk of death from cardiovascular disease following breast cancer: a systematic review","volume":"164","author":"Gernaat","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cjca.2026.03.051_bib26","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1093\/eurheartj\/ehz460","article-title":"Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study","volume":"40","author":"Abdel-Qadir","year":"2019","journal-title":"Eur Heart J"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26003016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26003016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:29:11Z","timestamp":1788834551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X26003016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0828282X26003016"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2026.03.051","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-Point Correction Factor Improves Accuracy of Framingham Risk Score in Breast Cancer Survivors","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2026.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}